18 results on '"Vivas, David"'
Search Results
2. Prospective observational registry of perioperative and periprocedural management of antithrombotic therapy in “real world”: the REQXAA study
3. Periprocedural use of antithrombotic therapy in interventional cardiology in Spain: are we doing better than other specialties?
4. Comments on the 2023 ESC guidelines for the management of endocarditis
5. Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU
6. Prospective observational registry of perioperative and periprocedural management of antithrombotic therapy in real-world patients: the REQXAA study
7. Ischemic Heart Disease and Acute Cardiac Care 2015: A Selection of Topical Issues
8. Effect of an Optimized Treatment With Insulin on Platelet Reactivity After Discharge in Patients With an Acute Coronary Syndrome and Hyperglycemia
9. Comments on the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice
10. Tako-tsubo Syndrome and Heart Failure: Long-term Follow-up
11. Reassessment of Blood Culture-Negative Endocarditis: Its Profile Is Similar to That of Blood Culture-Positive Endocarditis
12. Assessment of Myocardial Deformation: Predicting Medium-term left Ventricular Dysfunction after Surgery in Patients With chronic Mitral regurgitation
13. Ischemic Mitral Regurgitation and Non-ST-Segment Elevation Acute Myocardial Infarction: Long-Term Prognosis
14. Prognostic Value of First Fasting Glucose Measurement Compared With Admission Glucose Level in Patients With Acute Coronary Syndrome
15. Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology
16. Antithrombotic Therapy and Surgery: From Consensus to Clinical Practice. Response to Related Letters
17. Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU
18. Time Since Diabetes Onset as a Determining Factor in Platelet Reactivity. Response
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.